Quote:THL recommends that the two vaccines, Vaxigrip and Fluarix, reserved in the national vaccination programme for the seasonal influenza vaccinations are given to different age groups. Vaxigrip is recommended to people aged under 65 and Fluarix to people aged 65 and over.
Recent research at THL has focused on examining why the swine flu vaccine used in Canada, Arepanrix, which is similar to Pandemrix, has not been reported to have triggered narcolepsy. Preliminary research results suggest that the antigenic solution of Arepanrix is immunologically different to that of Pandemrix.
Of the seasonal influenza vaccines available in Finland this fall, the manufacturing process of Fluarix is similar to that of Pandemrix, with the exception that it does not contain any adjuvant. There is no evidence indicating that giving Fluarix to Pandemrix-vaccinated individuals could increase their risk of developing narcolepsy. Following the precautionary principle, however, THL does not recommend the administration of Fluarix to anyone under the age of 65. THL is not aware of any confirmed cases of narcolepsy associated with Pandemrix among persons aged 65 or over.
Precautionary principle indeed, and this would be the main reason:
Quote:According to the regional daily Keskisuomalainen, new legislation in the works guarantees lifelong care for patients suffering from narcolepsy as a result of receiving the Pandemrix swine flu vaccine.
The bill would entitle the narcolepsy patients to lifelong care from the state via the Pharmaceutical Injuries Insurance pool.
The daily reports that Social Affairs and Health Minister Paula Risikko as saying that government is preparing a bill that would allow the state to take on responsibility for paying compensation to the narcolepsy victims once the medical insurance pool runs out of funds to continue the payments.
Stay healthy folks.